These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the idea of targeting ACKR3 as a unique technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked Problems. Enhance healthier immune functionality: https://alanu689ofu1.bloguerosa.com/profile